“…These invasive responses observed in PC-TFF1 and MDCKts.src-TFF1 cells are blocked by pharmacological inhibitors targeting several oncogenic pathways implicated in cell motility, invasion and survival, including Rho GTPases (C3T, 3 mg/ml), Rho-kinase (Y27632, 10 mM), PI3 0 -kinase (WORT, 10 nM), PLCb (U73122, 1 mM), and COX-2 (NS398, 25 mM). According to our previous report (Rodrigues et al, 2001), TFF1 overexpression was associated with increased levels of the COX-2 protein.…”